Navigation Links
Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
Date:11/18/2011

CHAPEL HILL, N.C., Nov. 18, 2011 /PRNewswire/ -- Pharmaceutical organizations rely heavily on internal and external communications to increase their organizational effectiveness. Faced with a constantly evolving communication environment, companies need to align their internal and external communications with the most appropriate tactic.

It is difficult, however, to know which communication method is the most effective approach for the many internal and external communications topics, such as conveying product information and strategy guidance.

In a new study, Best Practices, LLC explores the various external and internal communication strategies and tactics and how people in pharma utilize various communication formats to achieve organizational objectives. The report, Communications Excellence: Tactics Used by Biopharma Executives to Increase Organizational Effectiveness, identifies the preferred channels and tools for communicating as well as optimum communication frequencies and approaches for both internal and external communications.

For instance, when communicating internally, email is the best tool for conveying information such as product information and general communications, according to the study. However, when communicating strategy guidance or vendor issues, face-to-face meetings are the most effective approach, study participants agreed.

The 107-page study, which attracted participants from 43 biopharma organizations, presents an array of insights across a number of critical communication fronts.

Key study objectives were:

  • External Communication: Tools and Usage Frequency
  • External Communication: Preference and Effectiveness
  • Internal Communication Type
  • Internal Communication: Medium and Preferences
  • Internal Communication Effectiveness

This new report will help pharmaceutical organizations improve the efficiency and effectiveness of their internal and external communication approaches and processes.

The study also provides key insights and metrics across a variety of internal and external communication issues such as preferred platforms for communicating with peers, superiors and subordinates; preferred formats for reviewing business-related information from external sources and what types of information participants wanted to receive from internal sources. These are just a few of the dozens of internal and external communication questions addressed in the new study.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1134.htm.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Atherotech to Exhibit its VAP(R) Cholesterol Test at Internal Medicine 2009 in Philadelphia
2. BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products
3. OriGene Technologies Launches Over 5,000 Heavy Isotope Labeled Full-Length Human Proteins as Quantitative Internal Standards for SRM/MRM Mass Spectrometry
4. Researchers use X-ray diffraction microscope to reveal 3-D internal structure of whole cell
5. USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration
6. DuPont Biotech Stewardship Program Gains External Certification
7. Everist Genomics Announces External Validation of OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
8. BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
9. Roka Bioscience Initiates External Trial for AOAC Certification
10. Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
11. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):